A historic day in structural heart.
On March 31st, Dr. Raj Makkar and the team at @smidtheart.bsky.social @cedarssinaihsu.bsky.social performed the first commercial #JenaValve #TAVR for severe AR in the U.S., a paradigm-changing advance for patients at high surgical risk.

Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection Emboline, Inc. has unveiled groundbreaking results from its PROTECT H2H trial, showcasing the Emboliner® system's potential in TAVR procedures. This innovative approach promises to redefine embolic protection standards in cardiac interventions.

Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection #USA #TAVR #Santa_Cruz #Emboliner #ACC_2026

Emboline's PROTECT H2H Trial Showcases Significant Advances in TAVR Embolic Protection Device Discover the groundbreaking results of Emboline's PROTECT H2H trial, presenting Emboliner® as a game-changer in TAVR procedures during ACC 2026.

Emboline's PROTECT H2H Trial Showcases Significant Advances in TAVR Embolic Protection Device #USA #TAVR #Santa_Cruz #Emboliner #ACC_2026

Commissions for Reapsneaky (FA)

#furry #art #dragon #NSFW #commissions #tavr

Commissions for Reapsneaky (FA)

#NSFW #tavr #dragon #commissions #furry

PROTECT H2H: Emboliner vs. Sentinel Embolic Protection Devices in #TAVR

Explore the findings from the trial unveiled during a Late-Breaking Clinical Trial session at #ACC26: https://bit.ly/4sFQK5r #CardioSky

Edwards Lifesciences Shares Rise 12% YTD on TAVR Growth Edwards Lifesciences reported FY2025 revenue of $6.2bn (+8% YoY); shares are up ~12% YTD as the TAVR market projects a 7.8% CAGR to 2030 (sources: Edwards, Grand View Research).

Edwards Lifesciences Shares Rise 12% YTD on TAVR Growth: Edwards Lifesciences reported FY2025 revenue of $6.2bn (+8% YoY); shares are up ~12% YTD as the TAVR market projects a 7.8% CAGR to 2030… Read full analysis 👉 #EdwardsLifesciences #TAVR #HealthcareInnovation #MedicalDevices #InvestmentNews

This commentary highlights that #TAVR in low-risk severe AS patients can achieve outcomes similar to #SAVR with bioprosthetic valves.

#OpenAccess: cvia-journal.org/aortic-steno...

Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement: The DEFINE-TAVR Prospective Study Transcatheter aortic valve replacement (TAVR) has transformed the treatment of severe aortic stenosis; however, up to 20% to 30% of patients continue to experience symptoms that limit quality of life ...

📢🆕Defining Exercise Hemodynamics & Function After #TAVR: The DEFINE-TAVR Prospective Study provides the first prospective evaluation of TAVR valve performance during exercise.

📖 jscai.org/article/S277...

🎙️Presented at #CRT2026 today!

#TranscatheterAorticValveReplacement #Echocardiogram #JSCAI

The Structural Heart Devices Market: A Surge Towards $12.93 Billion by 2032 As minimally invasive transcatheter therapies gain traction, the structural heart devices market is projected to soar, reaching nearly 13 billion dollars by 2032.

The Structural Heart Devices Market: A Surge Towards $12.93 Billion by 2032 #TAVR #London #United_Kingdom #Credence_Research #Heart_Valve_Devices

Commissions for Reapsneaky (FA)

#commissions #tavr #nude

Long-Term Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement Among Patients With Prior Mediastinal Radiation Limited data suggest that transcatheter aortic valve replacement (TAVR) is associated with similar short-term outcomes to surgical aortic valve replacement (SAVR) among patients with a history of medi...

📊5yr outcomes of #TAVR vs #SAVR in patients with mediastinal #radiation.

The Results?
✔️No significant differences in:
🔹All-cause mortality
🔹Stroke
🔹All-cause hospitalization

➡️ www.jscai.org/article/S277...

#StructuralHeart #RadiationHeartDisease #Radiotherapy

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial What to make of the results remains uncertain, but experts agree that greater vigilance in low-risk patients is warranted.

www.tctmd.com/news/higher-... #CardioSky #TAVI #TAVR

Two weeks in after a #TAVR procedure and feeling great.

6 yrs after surgery or #TAVR with CoreValve/Evolut, low-risk AS pts showed no difference in all-cause mortality or disabling #stroke in the Evolut Low-Risk trial. However, reinterventions were higher after TAVR, largely driven by increased AR. https://bit.ly/4csz87C

#JACC #vhdAS #SAVR #CardioSky

Cardiologists propose new 'coronary risk zone' approach for redo TAVR planning Redo TAVR can be challenging, requiring a significant amount of preprocedural CT planning. This proposed framework was designed to simplify that planning and help interventional cardiologists thrive. 

🫀Cardiologists are proposing a new “coronary risk zone” framework to simplify redo #TAVR planning, aimed at standardizing decision-making and improving patient care.

Read the full Cardiovascular Business article➡️ https://ow.ly/52wL50Yfk1C

#CardioSky

💡Explore the future of #Structural heart care at the #SCAI2026 Structural track! From #TAVR to #LAAO, tricuspid therapies, and PFO strategies, join expert sessions designed to help you master complex techniques.

View the Structural track program➡️ https://ow.ly/aaWM50Y6bfC

#CardioSky

🗨️SCAI, alongside leading #cardiology societies, submitted multispecialty comments to CMS on the #TAVR National Coverage Analysis. We will continue to monitor and respond as the proposed decision memo progresses.

Read the comments➡️ https://ow.ly/i1Jg50Y64nl

#SCAIAdvocacy #CardioSky

Mortality after urgent versus elective transcatheter aortic valve replacement: a systematic review and meta-analysis using reconstructed individual patient data from Kaplan–Meier curves - BMC Cardiova... Background Urgent transcatheter aortic valve replacement (TAVR), performed during unplanned hospitalizations, is linked to worse outcomes compared with elective TAVR. However, temporal trends in morta...

Urgent #TAVR tied to higher early mortality (HR 1.83, 95% CI 1.73-1.93) vs elective in #MetaAnalysis of 77k pts using reconstructed IPD from KM curves. Survival converges post-1yr, but elective yields 6.5-mo advantage. Favor early elective referrals for severe AS! link.springer.com/article/10.1...

📊New data show patients with paradoxical low‑flow, low‑gradient AS have higher 1‑year mortality after #TAVR compared with high‑gradient AS, highlighting the importance of nuanced hemodynamic assessment.

Learn more with this Cardiovascular Business article➡️ https://ow.ly/k1Me50Y6rjN

#CardioSky

Frontiers | Non-invasive pressure-volume analysis: a novel method for evaluating ventricular function in patients with aortic stenosis Background and aimsConventional echocardiographic measurements like ejection fraction (EF) and global longitudinal strain (GLS) evaluate left ventricular (LV...

Feasible non-invasive PV‑loops from 3D echo and estimated LV pressure show how TAVR alters stroke work, ventricular energetics, and ventriculo‑arterial coupling in severe AS patients. #TAVR #AorticStenosis #TAVI #3decho #pvloops #echocardiography

www.frontiersin.org/journals/car...

The Second Valve Drag and Reposition Technique for Rescue of Self-Expanding Aortic Valve Migration into the Left Ventricle during Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation Presenting "Second valve drag & reposition"- a novel technique to rescue a self-expanding aortic valve that migrated into the left ventricle

This #CVIA case report describes a novel 'second valve drag and reposition' technique to successfully rescue a self-expanding aortic valve that migrated into the left ventricle during #TAVR for pure #AorticRegurgitation. #Cardiology

#OpenAccess: cvia-journal.org/novel-techni...

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.

🫀Transcatheter valve procedures like #TAVR and pulmonary/tricuspid replacements may offer a less invasive option for patients with carcinoid heart disease, showing clinical improvement in early experience.

Learn more with this Cardiovascular Business article ➡️ https://ow.ly/mez450XWYXc

#CardioSky

Flow Gradients in Severe Aortic Stenosis and Preserved Ejection Fraction: A 10-Year Transcatheter Aortic Valve Replacement Study There are limited and conflicting data on the long-term outcomes in normal-flow low-gradient (NFLG) and paradoxical low-flow low-gradient (pLFLG) aortic stenosis (AS) following transcatheter aortic va...

📖Flow Gradients in Severe #AorticStenosis w Preserved EJ: A 10yr #TAVR Study⤵️

🔹pLFLG #AS: higher 1yr mortality (15.5% vs 10.8% HGAS)
🔹NFLG AS: similar outcomes to high-gradient AS
🔹5-year survival: no difference across groups

▶️www.jscai.org/article/S2772-9303(25)01...

✍️ Read about the level of implantation at the raphe (LIRA) method for #TAVR in bicuspid aortic valve ⬇️
onlinecjc.ca/article/S082...
#CardioSky #CJC

Intraprocedural TAVR heart block differs mechanistically from delayed block Factors predicting atrioventricular block during and after transcatheter aortic valve replacement procedures for aortic stenosis differ and may require different models for predicting risk.

#MedNews - Factors predicting #AVBlock during and after #TAVR procedures for aortic stenosis differ and may require different models for predicting risk.

Full story 👉 buff.ly/ZKfbP5P

#CardioSky

🎧🗣️ #JSCAIBEATS | Lucent Line & #TAVR
Experts break down real-world data published in #JSCAI on lucent line visualization during SAPIEN 3 TAVR & what the findings mean for implant technique — without compromising patient outcomes.

Spotify: bit.ly/3Zc3Mu8
Apple: bit.ly/4sFK0F0

TAVR remains a viable treatment strategy for cancer patients Improvements in care have resulted in a growing number of patients who go on to be diagnosed with both cancer and severe aortic stenosis. TAVR appears to be an effective treatment option for those individuals, and it may help them go on to receive life-saving cancer therapies.

🫀Patients with active cancer who undergo #TAVR show comparable outcomes to those without cancer. This suggests TAVR remains a viable treatment strategy even in complex oncology cases.

Learn more with this Cardiovascular Business article➡️ https://ow.ly/PhlJ50XTaWb

#CardioSky

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio on Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis Transcatheter aortic valve implantation (TAVI) has emerged as a revolutionary treatment for severe aortic stenosis, but predicting post-procedure outcomes remains challenging. This systematic review a...

TAVI has revolutionized valve care, but predicting post-op mortality remains a challenge. Can the Neutrophil-to-Lymphocyte Ratio (NLR) help?

doi.org/10.7759/cureus.77909

#WeiPublications #CardioSky #TAVR #MedSky #Cardiology #TAVI #Biomarkers #FOAMed

With transcatheter aortic valve replacement (#TAVR) Hussam Suradi, MD, uses a tiny device and high-tech procedure to open a narrowed aortic valve so the heart can pump smoothly again: https://rsh.md/4ptLfVQ